ZEISS Korea (CEO Jeong Hyun-seok) announced that it will participate in ‘BIO KOREA 2023’, which will be held at COEX in Seoul for three days from Wednesday, May 10th to Friday, May 12th.
The ZEISS Group is a company that has led global optical technology for 176 years, starting with its headquarters established in Oberkochen, Germany in 1846. Their innovative measurement solutions for industrial metrology and quality assurance, as well as microscopy solutions for life sciences and materials research, and medical technology solutions for ophthalmic and microsurgical diagnosis and treatment are highly regarded.
In particular, ZEISS has established itself as a key manufacturer of lithography optical modules required for semiconductor manufacturing, and is one of the most recognized companies in consumer products that utilize optical technology. Furthermore, the company explains that it is making continuous progress with optical solutions that represent technological innovation, including expanding its portfolio into future growth areas such as digital, healthcare, and automated production solutions.
As the Korean branch of these groups with a portfolio in the field of microscopy, ZEISS Korea plans to participate in BIO KOREA 2023 and introduce its latest digital slide scanner, ‘Axioscan 7’. Axioscan 7 is a product that boasts the ability to load up to 100 slides at once and scan them automatically. You can obtain general staining and fluorescence image results of cells, tissues, or objects, and based on the results, you can perform quantitative analysis of fluorescent substances as well as analysis of interactions between molecules.
In addition, ZEISS Korea will also exhibit the ‘LSM 9’ series, a confocal microscope. This is a confocal laser scanning microscope with the latest specifications and provides ultra-high resolution imaging functions of less than 100 nm (nanometer, 1 billionth of a meter) through the ultra-high resolution hardware module ‘Airyscan’ and ZEISS’ proprietary data processing technology.
A ZEISS Korea official said, “ZEISS is striving to be a reliable technology partner for domestic bio and pharmaceutical companies that strive to improve the global status of the Korean health industry and achieve sustainable growth. To this end, we propose better technology and the latest research solutions.” “We also plan to provide opportunities to directly demonstrate and experience the equipment at the exhibition site.”
He continued, “ZEISS is introducing new technologies, paying attention to customer needs arising from existing products, and reflecting them,” adding, “In particular, we have secured continuous education services related to the use of microscopes and professional personnel in charge of this. “We are guaranteeing customer-friendly service, so we ask for your interest,” he added.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.